RD
Roy D. Baynes
DELAYED 1 MONTH
Chief Medical Officer; Director
Eikon Therapeutics, Inc.
Nurix Therapeutics, Inc.
Travere Therapeutics, Inc.
Filings
5
Companies
3
Latest
May 19, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
61
TVTXCLUSTER 3
Travere Therapeutics, Inc.
Roy D. Baynes
Director
Sale
$209.9K
4,500 sh
May 7 12:00 AM
May 5, 2026
—
Travere Therapeutics, Inc.
Roy D. Baynes
Director
Option Exercise
$82.2K
4,500 sh
May 7 12:00 AM
May 5, 2026
—
Travere Therapeutics, Inc.
Roy D. Baynes
Director
Option Exercise
$66.5K
9,750 sh
May 4 8:27 PM
May 1, 2026